TSHA Taysha Gene Therapies PE ratio, current and historical analysis

The current PE ratio of TSHA cannot be calculated, as the latest EPS of -$0.36 is negative. The most recent PE ratio recorded for Taysha Gene Therapies was 3.19 in September 2024.

TSHA PE ratio history

How has TSHA's PE ratio performed in the past

Today

N/A

Average

N/A

Median

N/A

Minimum

N/A

Maximum

N/A

Taysha Gene Therapies PE ratio by year

Year	PE ratio	PE change	Price	EPS
2024	N/A	N/A	$1.73	-$0.36
2023	N/A	N/A	$1.77	-$0.96
2022	N/A	N/A	$2.26	-$3.78
2021	N/A	N/A	$11.65	-$4.64
2020	N/A	N/A	$26.54	-$3.4

Taysha Gene Therapies PE ratio by quarter (TTM)

Year	PE ratio	PE change	Price	EPS
Dec 2024	N/A	N/A	$1.73	-$0.36
Sep 2024	3.19	N/A	$2.01	$0.63
Jun 2024	N/A	N/A	$2.24	-$0.2
Mar 2024	N/A	N/A	$2.87	-$0.49
Dec 2023	N/A	N/A	$1.77	-$0.96
Sep 2023	N/A	N/A	$3.16	-$2.58
Jun 2023	N/A	N/A	$0.66	-$2.3
Mar 2023	N/A	N/A	$0.8	-$2.77
Dec 2022	N/A	N/A	$2.26	-$3.78
Sep 2022	N/A	N/A	$1.93	-$4.15
Jun 2022	N/A	N/A	$3.72	-$4.85
Mar 2022	N/A	N/A	$6.52	-$5.09
Dec 2021	N/A	N/A	$11.65	-$4.64
Sep 2021	N/A	N/A	$18.62	-$2.98
Jun 2021	N/A	N/A	$21.2	-$2.91

TSHA average PE ratio chart

What is the average PE ratio of TSHA for the past years

3-year avg

N/A

5-year avg

N/A

10-year avg

N/A

15-year avg

N/A

TSHA PE vs peers

What is TSHA's PE ratio compared to its peers

Stock name	PE ratio	Market cap
OLMA Olema Pharmaceuticals Inc	N/A	$319.12M
OMER Omeros Corp	N/A	$366.38M
VIVS VivoSim Labs Inc.	N/A	$2.88M
ORIC Oric Pharmaceuticals Inc	N/A	$378.19M
ORMP Oramed Pharmaceuticals Inc	N/A	$93.55M
TSHA Taysha Gene Therapies Inc	N/A	$430.5M

Frequently asked questions

What is Taysha Gene Therapies's PE ratio?

The current price to earnings ratio of TSHA cannot be determined, as its EPS of -$0.36 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.